When possible, the TRAC seminar presentations are recorded and available for online viewing. Due to the inclusion of unpublished research, some presentations may require viewers to log in to a JHED account in order to view the presentation.
Past Presentations
PUBLIC
- Olivia Kates, MD, MA – Developing TB Isolation Guidelines by Ethics
- Mercedes C. Becerra, ScD – 14th Annual Comstock Lecture & World TB Day Presentation – Counting children with tuberculosis: A biosocial perspective
- Petros C. Karakousis, MD – Host-Directed Therapies for TB: From the bench to clinical trials
- Katherine Robsky, PhD, MPH – Equity-oriented approaches to TB Control
- Lukas E. Brummer – Cost effectiveness of low-complexity screening tests in community-based screening for tuberculosis
- Yeon Soo Baik, PhD – Self-testing for TB – Can it be the wave for the future?
- Joga Gobburu, PhD, FCP, MBA – Precision Pharmacotherapy
- Mathangi Gopalakrishnan, MPharm, PhD – Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
JHED LOG IN REQUIRED
- Martina Kovarova, PhD – Long-acting in-situ forming implants for prevention and treatment of TB and other infectious diseases
- Rob van Wijk, PhD – Translational predictions of phase 2 efficacy studies for antituberculosis drugs
- Nicholas Paton, MD, FRCP – TRUNCATE-TB (Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive TB)
- Jyoti S. Mathad, MD, MSc – TB infection in pregnancy: Novel insights into immunology and prevention
- Laurence Borand, PharmD, PhD – TB-SPEED Pneumonia Study
- Styliani Karanika, MD – Therapeutic TB Vaccines
- Tess Ryckman, PhD – Cost-effectiveness of case finding and TB preventative treatment for household contacts and people with HIV
- Lucia Cilloni & Tushar Garg – The role of active case finding in ending TB – what is it, and what should it be? An interactive discussion
- 2022 TB Center and JHU TRAC Annual Meeting
- Umar Nasir, MPH – Sex Differences in Tuberculosis among People Living with HIV in Brazil
- Jeffrey Tornheim, MD, MPH – Pharmacokinetic Assessment of MDR-TB Drugs in the Treatment of TB Meningitis
- Sanjay K. Jain, MD; Elizabeth Tucker, MD; Camilo A. Ruiz-Bedoya, MD – The role of animal models and advanced molecular imaging in optimizing drug treatments for TB meningitis
- Michelle A. Rudek PharmD, PhD – Incorporation of Clinical Pharmacology into Preclinical Experiments and Clinical Trials: Focus on Diseases of the Brain and Meninges
- Mandar Paradkar TBM-KIDS Trial & Roeland Wasmann – Model-based approach for determining pediatric dosing of high-dose rifampicin, isoniazid, pyrazinamide, and whionamide (HRZEto) for children for WHO guidelines
- Maunank Shah, MD, PhD; Caitlin Reed, MD, MPH; Ruvandhi Nathavitharana, MD, MPH – Issues in the Clinical Management of Active TB
- Jeffrey Tornheim MD, MPH – DeCRyPT-ing Genotype-Phenotype Correlations, New Regimens, New Unknowns